Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

被引:506
作者
Bradford, Porcia T. [1 ]
Devesa, Susan S. [2 ]
Anderson, William F. [2 ]
Toro, Jorge R. [1 ]
机构
[1] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Natl Inst Hlth,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Natl Inst Hlth,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
B-CELL LYMPHOMA; WHO-EORTC CLASSIFICATION; MYCOSIS-FUNGOIDES; T-CELL; PROGNOSTIC-FACTORS; CLINICOPATHOLOGICAL FEATURES; FOLLICULAR LYMPHOMA; SURVIVAL; EPIDEMIOLOGY; SURVEILLANCE;
D O I
10.1182/blood-2008-10-184168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There have been no prior large population-based studies focusing on cutaneous lymphomas (CL) in the United States. Using the Surveillance, Epidemiology and End Results (SEER) program data, we analyzed age-adjusted CL incidence rates (IRs) and survival rates by sex and race/ethnicity. There were 3884 CLs diagnosed during 2001-2005. Cutaneous T-cell lymphomas(CTCLs) accounted for 71% (age-adjusted incidence rate [IR] = 7.7/1 000 000 person-years), whereas cutaneous B-cell lymphomas (CBCLs) accounted for 29% (IR = 3.1/1 000 000 person-years). Males had a statistically significant higher IR of CL than females (14.0 vs 8.2/1 000 000 person-years, respectively; male-female IR ratio [M/F IRR] = 1.72; P <.001). CL IRs were highest among blacks and non-Hispanic whites (both 11.5/1 000 000 person-years), followed by Hispanic whites (7.9) and Asian/Pacific Islanders (7.1). The CTCL IR was highest amongblacks (10.0/1 000 000 person-years), whereas the CBCL IR was highest among (non-Hispanic whites (3.5). Over the past 25 years, the CLIR increased from 5.0/1 000 000 person-years during 1980-1982 to 14.3 during 2001-2003. During 2004-2005, the CL IR was 12.7. This recent apparent change could be incomplete case ascertainment or potential leveling off of IRs. CLs rates vary markedly by race and sex, supporting the notion that they represent distinct disease entities. (Blood. 2009; 113: 5064-5073)
引用
收藏
页码:5064 / 5073
页数:10
相关论文
共 55 条
[1]   The non-Hodgkin lymphomas: A review of the epidemiologic literature [J].
Alexander, Dominik D. ;
Mink, Pamela J. ;
Adami, Hans-Olov ;
Chang, Ellen T. ;
Cole, Philip ;
Mandel, Jack S. ;
Trichopoulos, Dimitrios .
INTERNATIONAL JOURNAL OF CANCER, 2007, :1-39
[2]   Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database [J].
Anderson, WF ;
Chatterjee, N ;
Ershler, WB ;
Brawley, OW .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :27-36
[3]  
[Anonymous], 1975, SEER CANC STAT REV
[4]  
[Anonymous], 2013, International Classification of Disease for Oncology
[5]  
[Anonymous], CONVERSION NEOPLASMS
[6]  
Assaf Chalid, 2007, J Dtsch Dermatol Ges, V5, P662, DOI 10.1111/j.1610-0387.2007.06337.x
[7]   Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients [J].
Bekkenk, MW ;
Vermeer, MH ;
Jansen, PM ;
van Marion, AMW ;
Cunninga-van Dijk, MR ;
Kluin, PM ;
Geerts, ML ;
Meijer, CJLM ;
Willemze, R .
BLOOD, 2003, 102 (06) :2213-2219
[8]   PRIMARY CUTANEOUS T-CELL LYMPHOMA - CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC PARAMETERS OF 35 CASES OTHER THAN MYCOSIS-FUNGOIDES AND CD30-POSITIVE LARGE-CELL LYMPHOMA [J].
BELJAARDS, RC ;
MEIJER, CJLM ;
VANDERPUTTE, CJ ;
HOLLEMA, H ;
GEERTS, ML ;
BEZEMER, PD ;
WILLEMZE, R .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :53-60
[9]  
Bogle MA, 2005, J AM ACAD DERMATOL, V53, P479
[10]   Inflamm-aging: autoimmunity, and the immune-risk phenotype [J].
Boren, E ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2004, 3 (05) :401-406